WELLS FARGO & COMPANY/MN

Position in UNCY — Unicycive Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in UNCY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$103,503

+$103,233 QoQ

Shares Held

22,069

+110245.0% QoQ

Ownership

0.079%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#41

of 80 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. UNCY ranks #288 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	749,528	$372,313,040
2	HALO	Halozyme Therapeutics, Inc.	1,390,428	$108,828,797
3	ALNY	Alnylam Pharmaceuticals, Inc.	310,047	$93,333,446
4	REGN	Regeneron Pharmaceuticals, Inc.	140,802	$87,795,677
5	EXEL	Exelixis, Inc.	717,840	$39,057,673
6	RVMD	Revolution Medicines, Inc.	178,780	$33,481,916
7	ARGX	Argenx SE	34,453	$31,964,458
8	INCY	Incyte Corp	255,064	$28,914,053

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$103,503	22,069	+11159.7%	Shares	Defined	2026-08-14
2024-03-31	$270	196	+1.6%	Shares	Defined	2024-05-10
2023-12-31	$167	193	+394.9%	Shares	Defined	2024-02-09
2023-09-30	$33	39	-20.4%	Shares	Defined	2023-11-13
2023-06-30	$62	49	+4.3%	Shares	Defined	2023-08-15
2023-03-31	$98	47	+2.2%	Shares	Defined	2023-05-12
2022-12-31	$24	46	+2.2%	Shares	Defined	2023-02-13
2022-09-30	$26	45	+25.0%	Shares	Defined	2022-11-14
2022-06-30	$29	36	+9.1%	Shares	Defined	2022-08-12
2022-03-31	$42	33	+3.1%	Shares	Defined	2022-05-16
2021-12-31	$65	32	0.0%	Shares	Defined	2022-02-14
2021-09-30	$90	32	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.